90Y-Ibritumomab Tiuxetan Patient: Cumulated Activity, Organ Mass, Dose Calculated by VSV and 3D-RD, and Relative Differences for Corresponding ROIs
| ROI | Cumulated activity (MBq·s) | Mass (g) | Dose for VSV (Gy) | Dose for 3D-RD 108 histories (Gy) | Percentage relative difference with VSV | Voxel-to-voxel ratio mode |
| Liver | 4.02E+07 | 1,241 | 2.78 | 2.77 | 0.25 | 0.996 (0.024) |
| Spleen | 1.16E+07 | 323.1 | 3.02 | 3.01 | 0.13 | 0.996 (0.023) |
| Left kidney | 3.18E+06 | 124.7 | 2.14 | 2.14 | 0.09 | 0.995 (0.023) |
| Right kidney | 3.91E+06 | 112.4 | 2.89 | 2.89 | 0.17 | 0.996 (0.027) |
Data in parentheses are SDs.